About NFXF

This author has not yet filled in any details.
So far NFXF has created 482 blog entries.

Thank You, 2012 Fundraisers!

By |2013-01-16T07:25:23-05:00Jan 16, 2013|2012, Fundraiser|

We hope your new year is off to a great start! This month we will take a moment to recognize the many individuals, families, students and LINKS groups who took it upon themselves to raise [...]

LINKS Gets Into Gear for the New Year!

By |2013-01-02T13:14:41-05:00Jan 2, 2013|Community Support Network|

2012 was the most active year ever in the LINKS Support Network program, with everything from monthly Saturday gatherings for coffee to statewide awareness walks dotting the calendar. In addition to actively participating at the International Conference, many LINKS groups held local educational conferences for families and professionals in their communities. We also saw a lot of growth in the LINKS network, with eight new groups forming and two groups changing leadership. All this activity helped us reach out to more families across the U.S. than ever before.

A Fond Farewell to the FX Community

By |2012-12-31T08:06:51-05:00Dec 31, 2012|Annoucements|

My first Fragile X case was in graduate school in 1984. A young man, about to be married, had a brother with Fragile X syndrome, and he wanted genetic counseling prior to his wedding. The first rumblings of "transmitting males" were arising so we imparted on him a small risk to be some sort of carrier, with no symptoms, and to be at risk for grandchildren with FXS. Even then, that was pretty advanced stuff, straying from the usual X-linked inheritance that previously reassured unaffected males that they could not pass on the disorder.

Seaside Therapeutics Harbor-C Trials

By |2012-11-06T11:08:49-05:00Nov 6, 2012|Opportunities for Families|

Seaside Therapeutics is studying the science of the brain and working to deliver treatments that improve the underlying causes of developmental disorders like Fragile X syndrome. Right now, Seaside is testing an investigational medicine called STX209 (arbaclofen) for individuals with Fragile X syndrome with social impairment. Thanks to the dedication and efforts of families, one of the clinical trials is almost complete.

Changing Minds: Advocates Reshape How We Think About Autism

By |2012-11-05T08:42:00-05:00Nov 5, 2012|In the News|

Brandon Reynolds, the author of the article Changing Minds: Advocates Reshape How We Think About Autism which recently appeared in the SF Weekly, has a brother with Fragile X syndrome and has been a past contributor to the NFXF’s Foundation Quarterly. The article features quotes from our executive director, Robert Miller, FX expert and medical director at UC Davis’ MIND Institute, Randi Hagerman, and several FX parents.

What is #GivingTuesday?

By |2020-12-01T14:27:37-05:00Oct 31, 2012|2012, Fragile Xtras|

Thanksgiving is right around the corner, and for most people that means spending time with family while enjoying great meals, good times, and a big helping of gratitude. Then comes Black Friday, the day [...]

Load More Posts